株式会社モダリス
Tokyo, JP · Founded 2016 · 6 known investors
Find your way into 株式会社モダリス
Sign up to see every warm intro you have to 株式会社モダリス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社モダリス team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.
Founders & leadership
株式会社モダリス was founded in 2016 by Haruhiko Morita.
Investors · 6
How we know: Medical Incubator Japan K.K.'s portfolio page · Not right? Tell us
How we know: Nippon Venture Capital's portfolio page · Not right? Tell us
How we know: SBI Shinsei Corporate Investment's portfolio page · Not right? Tell us
How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 4
Companies working in the same space as 株式会社モダリス.
Frequently asked questions
- What does 株式会社モダリス do?
- Modalis Therapeutics develops therapeutics using CRISPR gene-editing technology and provides its platform technology for drug development. It operates in the biotechnology sector.
- Who founded 株式会社モダリス?
- 株式会社モダリス was founded by Haruhiko Morita in 2016.
- Who are 株式会社モダリス's investors?
- 株式会社モダリス's investors include Medical Incubator Japan K.K., Nippon Venture Capital, SBI Shinsei Corporate Investment, Shinsei Capital Partners, SMBC Venture Capital, UTokyo Innovation Platform Co. Ltd..
- Where is 株式会社モダリス headquartered?
- 株式会社モダリス is headquartered in Tokyo, JP.

